HEARS-SLP: Providing SLP-Delivered Hearing Health Care to Individuals With Cognitive Impairment
NCT ID: NCT06008782
Last Updated: 2026-01-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
20 participants
INTERVENTIONAL
2023-12-15
2026-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Baltimore HEARS: Hearing Health Equity Through Accessible Research & Solutions
NCT03442296
HEARS-NPS: Addressing Hearing Loss as a Common Unmet Contributor of Neuropsychiatric Symptoms
NCT06930560
The Baltimore HEARS Pilot Study
NCT02045511
Aging, Cognition, and Hearing Evaluation in Elders Study
NCT02412254
Effectiveness Speech and Cognitive Therapy Implant Pre-cohlear Implantation
NCT04907929
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Immediate treatment
immediate treatment
HEARS-SLP device
Tailored fitting and programming of a personal sound amplifier. This will be accompanied by a component of aural rehabilitation.
HEARS-SLP program
Tailored aural rehabilitation for participant and communication partner
Delayed treatment
1 month delayed treatment
HEARS-SLP device
Tailored fitting and programming of a personal sound amplifier. This will be accompanied by a component of aural rehabilitation.
HEARS-SLP program
Tailored aural rehabilitation for participant and communication partner
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
HEARS-SLP device
Tailored fitting and programming of a personal sound amplifier. This will be accompanied by a component of aural rehabilitation.
HEARS-SLP program
Tailored aural rehabilitation for participant and communication partner
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* English-speaking
* Lives at home
* Diagnosis of probable Alzheimer's Disease or other related dementia according to the core clinical criteria outlined in the National Institute on Aging (NIA) and Alzheimer's Association Guidelines
* Availability of caregiver/study partner to participate in all study-related visits and who provides ≥8 hours of weekly oversight/care
* Speech frequency pure tone average (0.5- 4 kHz) \>25 db in the better-hearing ear; adult onset hearing loss
* Stable (for 2 weeks or longer) dosing of medication (e.g. antidepressants, antipsychotics) for neuropsychiatric symptoms
Exclusion Criteria
* Medical contraindication to use hearing aids ( e.g. draining ears)
* Inability to participate in the 1-month follow up
60 Years
100 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Aging (NIA)
NIH
Johns Hopkins University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Esther Oh, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Johns Hopkins School of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Johns Hopkins Medicine
Baltimore, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB00218068
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.